ELDN SG&A Expense Growth
Eledon Pharmaceuticals Inc · SG&A Expense Growth
ELDN SG&A Expense Growth
Latest reported-8.75%period ending
ELDN FY SG&A Growth (YoY) (0.00% → -8.75%)
Latest values, visible window
High-resolution chart · PNG
ELDN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -8.7519% | |
| 46.6977% | |
| -0.0945% | |
| -3.2897% | |
| 30.6407% | |
| 71.127% | |
| -18.901% | |
| -34.7419% | |
| -15.2683% | |
| 3.7709% | |
| 42.0709% | |
| 150.4228% | |
| 55.6823% | |
| 0% |